Lucid Diagnostics INC Form 4 insider transactions
NASDAQ
Form 4: Lucid Diagnostics CEO Aklog Lishan Reports Acquisition of 400,000 Shares of Restricted Stock
Lucid Diagnostics CEO Aklog Lishan reported the acquisition of 400,000 shares of restricted stock and provided an update on beneficial ownership.